As global interest in weight loss remedies grows, the off-label use of diabetes medication Ozempic for shedding pounds in non ...

India has officially approved and launched Mounjaro (tirzepatide), a groundbreaking injectable medication for the treatment of Type 2 diabetes and obesity. Developed by Eli Lilly and Company, the drug ...

A Cleveland Clinic study shows that semaglutide and tirzepatide—injectable GLP-1 drugs for obesity—produce smaller weight ...

The following is a summary of “Oral semaglutide for the treatment of obesity: a retrospective real-world study,” published in ...

Given the evidence, the committee has recommended that the labels for Novo Nordisk’s Wegovy and Ozempic be updated to include ...

The small, 48-subject study – published in the journal JAMA Psychiatry – compared weekly injections with a low dose of semaglutide (0.25mg) to placebo over a nine-week period and found ...

That figure included ₹75M sales of the drug’s 5mg version, indicating over a ... has yet to roll out its popular weight loss therapy semaglutide in India, the world's most populous country ...

EPA Administrator Lee Zeldin said Texas is best positioned to protect its drinking water while enabling lucrative CO2 injection projects to proceed. "EPA is taking a key step to support ...

While it also offers medication-assisted programmes, including Mounjaro or tirzepatide, as well as Wegovy or semaglutide treatments ... Emma was initially prescribed 2.5mg of Mounjaro, losing ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.